Knockout of NRF2 triggers prostate cancer cells death through ROS modulation and sensitizes to cisplatin.

Published in:

Journal of Cellular Biochemistry, 2022, v. 123, n. 12, p. 2079, doi. 10.1002/jcb.30333

By:

• Mancini, Mariana C. S.;
• Morelli, Ana P.;
• Severino, Matheus B.;
• Pavan, Isadora C. B.;
• Zambalde, Érika P.;
• Góis, Mariana M.;
• Silva, Luiz G. S. da;
• Quintero‐Ruiz, Nathalia;
• Romeiro, Caio F.;
• dos Santos, Daniel F. G.;
• Bezerra, Rosângela M. N.;
• Simabuco, Fernando M.

Publication type:

Article